Wednesday, December 25, 2019 7:03:50 PM
I do believe that many of us fail to see the potential here. Someone actually bought the stock for roughly $.007 a week or so ago, that person now has nearly a 400% gain. In reality there is no difference between a stock rising from $.007 to $.028 and $7 to $28, or $70 to $280, it all depends on how many shares you buy, the percentage gain is the same. I know of few shares that move from $70 to $280 in weeks, or months, but it often occurs in years. $.007 to $.028 in a few weeks is rare, but certainly far more common then if the stock were ten, one hundred, or a thousand times that price. I certainly wasn't a buyer at $.007, but hindsight is always 20/20. I cannot remember precisely when we were above $3, but today we have reason to believe it could happen again. It won't happen this year, perhaps not next, but who'd be unhappy if it took 2 to 5 years to happen. I believe anything is possible if we get more patent approvals and/or positive clinical trial results for products where we own the intellectual property.
Gary
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM